Apr 16, 2020 / 01:00PM GMT
Editor
Good day and welcome to the bioMérieux first-quarter 2020 business review conference call. Today's conference is being recorded. At this time I would like to turn the conference over to Sylvain Morgeau. Please go ahead, sir.
Sylvain Morgeau - bioMérieux SA-Manager of IR
Thank you, Mary. Good afternoon and thank you for joining us to review our Q1 2020 activity. As usual I am online with Alexandre Mérieux, Chairman and CEO, as well as Guillaume Bouhours, our CFO.
Before I leave the call over to Alexandre for preliminary remarks, please note that this conference call will include forward-looking statements. I would like to remind you of the usual disclaimer saying that forward-looking statements are based entirely or partially on adjustments or judgments that may change or be modified due to uncertainties and risk related to the Company's environment and, notably, those that are described in 2019 universal registration documents.
Those uncertainties include but are not limited to economic conditions, financial
Q1 2020 Biomerieux SA Corporate Sales Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot